Author name: DrugPatentWatch

Introduction: Beyond the Generic Cliff and the NME Gamble Welcome. If you’re reading this, you’re likely standing at the precipice […]

The High-Stakes Game: A Modern Framework for Pharmaceutical Portfolio Risk In the world of investing, we often categorize assets along

1.0 Introduction: The Strategic Imperative of Patent-Informed Formulary Planning In the intricate and high-stakes world of national healthcare, the management

Executive Summary The global generic drug market, a sector valued at over USD 491 billion in 2024 and projected to

Part I: The Anatomy of the Patent Cliff The business model of the innovative pharmaceutical industry is built upon a

In the high-stakes world of pharmaceutical development, a patent is more than just a legal document; it’s the lifeblood of

In the age of big data, the world’s collective drug patent databases are the equivalent of satellite imagery for an

Litigation Summary and Analysis for Liu v. The Unincorporated Associations Identified on Schedule A | 1:25-cv-02296 Executive Summary This report

Executive Summary This report provides a comprehensive strategic framework for Active Pharmaceutical Ingredient (API) sourcing tailored to the unique pressures